REL900 (Lovaza omega-3-acid ethyl esters 1000 mg)
Generic Name: omega-3 polyunsaturated fatty acids
Pill with imprint REL900 is Clear, Capsule-shape and has been identified as Lovaza omega-3-acid ethyl esters 1000 mg. It is supplied by GlaxoSmithKline.
Lovaza is used in the treatment of hypertriglyceridemia; dietary supplementation and belongs to the drug class nutraceutical products. Risk cannot be ruled out during pregnancy. Lovaza omega-3-acid ethyl esters 1000 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for REL900
- Generic Name:
- omega-3 polyunsaturated fatty acids
- omega-3-acid ethyl esters 1000 mg
- 24.00 mm
- Rx and/or OTC
- Drug Class:
- Nutraceutical products
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Inactive Ingredients:
Note: Inactive ingredients may vary.
More about Lovaza (omega-3 polyunsaturated fatty acids)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews – Add your own review/rating
- Generic Availability
- Drug class: nutraceutical products
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.